Sandoz Group AG

Sandoz Group AG is a Swiss pharmaceutical company that develops, manufactures and sells generic medicines and biosimilars. Having operated for many years as a division of Novartis, Sandoz was separated as a standalone company in October 2023, and its shares began trading on the Swiss stock exchange SIX under the ticker SDZ.

The company's portfolio is divided into two main groups. Generic medicines are equivalents of drugs whose patent protection has expired; Sandoz offers tablet, injection and inhaler forms across a wide range that includes antibiotics, cardiovascular drugs, painkillers and central nervous system drugs. Biosimilars are equivalents of biologic drugs whose clinical equivalence has been proven; the company offers these products in areas such as immune system diseases, oncology and osteoporosis. Its products are sold in many countries through hospitals, pharmacies and public procurement bodies.

Those following Sandoz track the timing of biosimilar launches, patent disputes, generic drug price pressure in Europe and the US, tenders and supply security policies. The Sandoz page on Lzzo.com shows the price on a US dollar basis; users can select the Turkish lira, euro or pound sterling equivalent. A historical chart, technical indicators, and source and last update information are also included.